Hjem › Autoimmune sygdomme › New York
Autoimmune sygdomme kliniske forsøg i New York
24 studier for Autoimmune sygdomme søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- St Lawrence Health System, Potsdam
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07621809Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
RekruttererFase 2
Alder 16 til 70 · Alle køn · Opdateret 17. sep. 2026 · NCT07328581RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
- Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients, The Bronx
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology, Great Neck
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
- Northwell Health, Great Neck
- NYU Langone, New York
- Hospital for Special Surgery, New York
- og 1 flere
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT05671757A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- NY Cancer and Blood Specialists, Shirley
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 11. sep. 2026 · NCT07059000A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06948318A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT04474847RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Columbia University Irving Medical Center, New York
- University of Rochester, Rochester
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 17. aug. 2026 · NCT06858319RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Columbia University, New York
- University of Rochester Medical Center, Rochester
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 13. aug. 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1036, New York
- Site Number - 1034, New York
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916Autoimmune and Autoinflammatory Genetics Study
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Month · Alle køn · Opdateret 8. jul. 2026 · NCT06004349A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- og 9 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Columbia University, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. maj 2026 · NCT04422912A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Columbia University Irving Medical Center, New York
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT06626919Biologics And Clinical Immunology Cohort at Sinai
- Mount Sinai, New York
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT04784364Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Op til 99 år · Alle køn · Opdateret 4. feb. 2026 · NCT05584488Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.